Medical contributor
Clinical Professor of Infectious Diseases; Medical Director, Stanford Antimicrobial Safety and Sustainability Program; Co-Director, WHO Collaborating Center for Antimicrobial Stewardship
Stanford Medicine
Marisa Holubar, MD, MS, FIDSA, is a Medical contributor for narrowly matched material concerning infectious diseases, antimicrobial stewardship, and antibiotic safety.
Professional background
Marisa Holubar, MD, MS, FIDSA, is a Clinical Professor of Infectious Diseases at Stanford, Medical Director of the Stanford Antimicrobial Safety and Sustainability Program and Co-Director of the WHO Collaborating Center for Antimicrobial Stewardship.
Clinical Professor of Medicine (Infectious Diseases), Stanford; Fellow of IDSA since 2023; Interim Division Co-Chief, Infectious Diseases and Geographic Medicine since 2024; Medical Director, Stanford Antimicrobial Safety and Sustainability Program since 2021; Co-director, WHO Collaborating Center for Antimicrobial Stewardship since 2019.
Antibiotic safety perspective
- Antimicrobial stewardship
- Her Stanford program roles document a sustained focus on antimicrobial stewardship.
- Infectious diseases
- Her clinical appointment is within infectious diseases at Stanford.
- Antibiotic safety
- Antibiotic safety is included in the approved contributor scope for this site.
Training and program leadership
Affiliation: Stanford Medicine
Position: Clinical Professor of Infectious Diseases; Medical Director, Stanford Antimicrobial Safety and Sustainability Program; Co-Director, WHO Collaborating Center for Antimicrobial Stewardship
- MD, University of Wisconsin School of Medicine, 2005
- Residency, Brown University School of Medicine, 2009
- Fellowship, Stanford, 2013
- MS in Epidemiology and Clinical Research, Stanford, 2014
- Board certification, Internal Medicine, ABIM, 2009
- Board certification, Infectious Disease, ABIM, 2024